Search Ontology:
ChEBI
imatinib
- Term ID
- CHEBI:45783
- Synonyms
-
- 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE
- 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide
- alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide
- imatinib
- STI 571
- Definition
- A benzamide obtained by formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary aromatic amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine. Used (as its mesylate salt) for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours.
- References
-
- Beilstein:7671333
- CAS:152459-95-5
- DrugBank:DB00619
- Drug_Central:1423
- HMDB:HMDB0014757
- KEGG:D08066
- LINCS:LSM-1023
- PDBeChem:STI
- PMID:14660054
- PMID:14715630
- PMID:15073101
- PMID:15170967
- PMID:15722647
- PMID:15794712
- PMID:15966213
- PMID:16122278
- PMID:16826359
- PMID:16983347
- PMID:17190842
- PMID:17410337
- PMID:17457302
- PMID:17717205
- PMID:18193246
- PMID:18216472
- PMID:18337118
- PMID:18344535
- PMID:18376233
- PMID:18407734
- PMID:18420270
- PMID:18423008
- PMID:18548219
- PMID:18623899
- PMID:18780518
- PMID:18809244
- PMID:19020005
- PMID:19052981
- PMID:19077095
- PMID:19097599
- PMID:19182535
- PMID:19242505
- PMID:19415889
- PMID:19527930
- PMID:19591692
- PMID:19693287
- PMID:19749465
- PMID:19810774
- PMID:19853594
- PMID:19920908
- PMID:22891806
- PMID:23075630
- PMID:23183914
- PMID:23313020
- PMID:23394269
- PMID:23480638
- PMID:23503753
- PMID:23536338
- PMID:23574742
- PMID:23580311
- PMID:23587588
- Patent:EP564409
- Patent:US5521184
- Reaxys:7671333
- Wikipedia:Imatinib
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
- has_role
-
- inverse has_functional_parent
-
- inverse has_part
-
Phenotype
Phenotype resulting from imatinib
Phenotype where environments contain imatinib
Phenotype modified by environments containing imatinib
Human Disease Model